 BOULDER, Colo.--BUSINESS WIRE--- BDSX patientsfirst--Biodesix, Inc. Nasdaq: BDSX, a leading data-driven diagnostic solutions company with a focus on lung disease, today announced that it will release financial results for the second quarter ended June 30, 2022 before the open of trading on Thursday, August 4. Biodesixs management will host a conference call and webcast to discuss its financial results and provide a general business update at 8:00 a.m. Eastern Time on the same day. Dial-in and call details are a 